Loading
Latest filing published 12 Mar 2021 for Interpace Biosciences, INC..
No signal scores available.
This profile gathers the share dealings of Thomas John Freeburg in Interpace Biosciences, Inc. The record holds 2 filings, for trades running from 13 March 2019 to 10 March 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 12 March 2021, reports a share grant in Interpace Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations